Companies: 10,795·Total market cap: $144.5T

Lunai Bioworks Inc.

Lunai Bioworks Inc.

LNAINASDAQHealthcare● Active

$2.37

$-0.08(-3.27%)

Market Cap$10745319

P/E Ratio—

52W High$33.52

52W Low$1.208

Avg Volume2.7M

Open$2.46

Beta0.36

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Lunai Bioworks Inc.（LNAI）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · LNAI · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-61.25Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)20942.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding2.1MShares outstanding history

Next EarningsTBAEarnings history

探索 Lunai Bioworks Inc. 数据

分析师预测—

股息不分红

盈利EPS $-86.24-18.46%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$178.0M▼ 101.31% YoY

202320242025

FY 2025EPS$-86.24▼ 18.46% YoY

202320242025

TTM:Revenue: $20942.00Net Income: -$128.3MEPS: $-61.25View income statement →

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Lunai Bioworks Inc.

$2.37-3.27%$10.7M #2

Adaptimmune Therapeutics plc

$0.05-3.00%$12.5M #3

Adlai Nortye Ltd.

$10.23+2.81%$543.0M #4

Apollomics, Inc.

$14.00+0.00%$15.4M #5

$3.25+0.62%$14.1M #6

Ernexa Therapeutics Inc.

$7.39-6.34%$2.3M

股票表现

1D-3.27%

1W-21.00%

1M-10.23%

3M+27.42%

YTD-66.38%

1Y-87.01%

5Y-87.01%

关于 Lunai Bioworks Inc.

CEODavid H. Weinstein

IPO DateSep 30, 2025

Employees29

CountryUS

Websiterenovarogroup.com

Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological d…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Lunai Bioworks Inc.（LNAI）是 Biotechnology 行业的 Healthcare 类公司，于 Sep 30, 2025 在 NASDAQ 上市。截至最近交易日，LNAI 股价为 $2.37，市值约为 $10.7M。过去12个月累计回报 -87.01%，年初至今回报 -66.38%。

2025 财年 Lunai Bioworks Inc. 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。

常见问题

截至最近一个交易日，Lunai Bioworks Inc.（LNAI）股价为 $2.37，在 NASDAQ 上市，52周区间为 $1.21 – $33.52。

LNAI 最新股价LNAI quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议